Is Staphylococcus aureus susceptible to Augmentin (amoxicillin-clavulanate)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

No, Staphylococcus aureus is not reliably susceptible to Augmentin (amoxicillin-clavulanate) due to the prevalence of beta-lactamase-producing strains and the potential for methicillin-resistance. The effectiveness of Augmentin against S. aureus depends on the specific strain and its resistance patterns. While the clavulanic acid component in Augmentin can inhibit beta-lactamase, which is an enzyme produced by some S. aureus strains to resist penicillin-type antibiotics, methicillin-resistant Staphylococcus aureus (MRSA) strains are resistant to Augmentin 1. For skin and soft tissue infections, guidelines recommend using agents active against S. aureus, such as dicloxacillin or cephalexin for methicillin-susceptible strains, and doxycycline, clindamycin, or sulfamethoxazole-trimethoprim for MRSA 1.

  • Key considerations for treating S. aureus infections include:
    • Confirming susceptibility through culture and sensitivity testing, especially in severe cases or when MRSA is suspected
    • Using appropriate antimicrobial therapy based on the specific strain and resistance pattern
    • Completing the full course of antibiotics to prevent recurrence and antimicrobial resistance
  • It's crucial to note that the provided guideline evidence from 2014 does not specifically recommend Augmentin for S. aureus infections, instead suggesting other agents as first-line treatments 1.

From the FDA Drug Label

Amoxicillin/clavulanic acid has been shown to be active against most isolates of the following bacteria, both in vitro and in clinical infections as described in the INDICATIONS AND USAGE section Gram-positive bacteria Staphylococcus aureus

Susceptibility of Staphylococcus aureus to Augmentin (amoxicillin-clavulanate):

  • Yes, Staphylococcus aureus is susceptible to Augmentin (amoxicillin-clavulanate) 2.

From the Research

Susceptibility of Staphylococcus aureus to Augmentin

  • The provided studies do not directly address the susceptibility of Staphylococcus aureus to Augmentin (amoxicillin-clavulanate) 3, 4, 5, 6, 7.
  • However, the studies discuss the resistance patterns of Staphylococcus aureus to various antibiotics, including methicillin-resistant Staphylococcus aureus (MRSA) 3, 4, 5, 6, 7.
  • Methicillin resistance in Staphylococcus aureus is associated with resistance to semi-synthetic penicillins, which includes amoxicillin 6.
  • The use of amoxicillin-clavulanate (Augmentin) may not be effective against MRSA due to its resistance to methicillin and semi-synthetic penicillins 6.
  • Other antibiotics, such as vancomycin, linezolid, and daptomycin, are effective against MRSA, but their use is limited by increasing resistance and side effects 3, 4, 7.

Alternative Treatment Options

  • The studies suggest that alternative treatment options, such as clindamycin, trimethoprim-sulfamethoxazole, and doxycycline, may be effective against Staphylococcus aureus, including MRSA 3, 4, 5.
  • However, the efficacy of these antibiotics may vary depending on the specific strain of Staphylococcus aureus and the severity of the infection 3, 4, 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment of infections due to resistant Staphylococcus aureus.

Methods in molecular biology (Clifton, N.J.), 2014

Research

Treatment of infections caused by resistant Staphylococcus aureus.

Methods in molecular biology (Clifton, N.J.), 2007

Research

Methicillin-resistant Staphylococcus aureus: related infections and antibiotic resistance.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.